Evidence map›Paper›PMID 33302735›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2021

Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma.

Chunyang Chen, Xinyu Geng, Rui Liang, Dongze Zhang, Meiyun Sun, Guangbo Zhang, Jianquan Hou

Abstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chunyang ChenDepartment of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, People's Republic of China.ORCID 0000-0002-1897-0414
Xinyu GengDepartment of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, People's Republic of China.
Rui LiangDepartment of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, People's Republic of China.
Dongze ZhangJiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou 215006, People's Republic of China.
Meiyun SunJiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou 215006, People's Republic of China.
Guangbo ZhangJiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou 215006, People's Republic of China.
Jianquan HouDepartment of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, People's Republic of China.ORCID 0000-0002-3445-2625

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study built and tested two effective nomograms for the purpose of predicting cancer-specific survival and overall survival of chromophobe renal cell carcinoma (chRCC) patients. Multivariate Cox regression analysis was employed to filter independent prognostic factors predictive of cancer-specific survival and overall survival, and the nomograms were built based on a training set incorporating 2901 chRCC patients in a retrospective study (from 2004 to 2015) downloaded from the surveillance, epidemiology, and end results (SEER) database. The nomograms were verified on a validation cohort of 1934 patients, subsequently the performances of the nomograms were examined according to the receiver operating characteristic curve, calibration curves, the concordance (C-index), and decision curve analysis. The results showed that tumor grade, AJCC and N stages, race, marital status, age, histories of chemotherapy, radiotherapy and surgery were the individual prognostic factors for overall survival, and that AJCC, N and SEER stages, histories of surgery, radiotherapy and chemotherapy, age, tumor grade were individual prognostic factors for cancer-specific survival. According to C-indexes, receiver operating characteristic curves, and decision curve analysis outcomes, the nomograms showed a higher accuracy in predicting overall survival and OSS when compared with TNM stage and SEER stage. All the calibration curves were significantly consistent between predictive and validation sets. In this study, the nomograms, which were validated to be highly accurate and applicable, were built to facilitate individualized predictions of the cancer-specific survival and overall survival to patients diagnosed with chRCC between 2004 and 2015.

Indexed as

NomogramsAgedArea Under CurveCalibrationCarcinoma, Renal CellClinical Decision-MakingDisease-Free SurvivalFemaleHumansKidney NeoplasmsMaleMiddle AgedMultivariate AnalysisNeoplasm StagingPrognosisProportional Hazards Modelscancer-specific survivalchromophobe renal cell carcinomaNomogramoverall survivalprognosisSEER

Identifiers

PMID33302735
PMCPMC7988723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.